Arch Venture Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-716,392	Closed	-$11.1M	–	6
2019 Q3	$11.1M	Sell	716,392 -256,798	-26%	-$3.99M	12.18%	4
2019 Q2	$19.8M	Sell	973,190 -300,000	-24%	-$6.09M	20.45%	3
2019 Q1	$22.4M	Sell	1,273,190 -800,000	-39%	-$14.1M	21.6%	3
2018 Q4	$26.6M	Buy	+2,073,190	New	+$26.6M	26.59%	2